School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510275, PR China.
Eur J Med Chem. 2012 Sep;55:346-57. doi: 10.1016/j.ejmech.2012.07.039. Epub 2012 Jul 31.
A series of new 4-arylidene curcumin analogues (4-arylidene-1,7-bisarylhepta-1,6-diene-3,5-diones) were synthesized and found to be potent antiproliferative agents against a panel of cancer cell lines at submicromolar to low micromolar concentrations by SRB assay. Their inhibitory abilities against NF-κB was evaluated by High Content Analysis (HCA) based immunofluorescence assay; and the Akt signalling inhibition was determined by fluorescence polarization assay and western blot respectively. The Structure-Activity Relationship was discussed. Our results revealed that 4-arylidene curcumin analogues may work in a multi-targets manner in cancer cell.
一系列新的 4-芳基二氢茚满酮类似物(4-芳基-1,7-双芳基庚-1,6-二烯-3,5-二酮)被合成,并通过 SRB 试验发现它们在亚毫摩尔至低毫摩尔浓度范围内对一系列癌细胞系具有很强的抗增殖活性。通过基于高内涵分析(HCA)的免疫荧光测定法评估它们对 NF-κB 的抑制能力;通过荧光偏振测定法和 Western blot 分别测定 Akt 信号传导抑制。讨论了结构-活性关系。我们的结果表明,4-芳基二氢茚满酮类似物可能在癌细胞中以多靶点方式发挥作用。